Skip to content

MANAGEMENT OF THE PATIENT WITH ACUTE Abdomen abdominal SURGERY UNDER URGENT: Multicentre randomized PILOT STUDY - SURE VOLUME

MANAGEMENT OF THE PATIENT WITH ACUTE Abdomen abdominal SURGERY UNDER URGENT: Multicentre randomized PILOT STUDY - SURE VOLUME

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-014659-59-IT
Enrollment
Unknown
Registered
2009-12-04
Start date
2010-04-20
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with acute abdomen in which to proceed is necessary to intervention in regime of urgency. MedDRA version: 9.1 Level: SOC Classification code 10042613

Interventions

Pharmaceutical Form: Solution for infusion INN or Proposed INN: Electrolytes Concentration unit: mEq/l milliequivalent(s)/litre Concentration type: equal Concentration number: 154-

Sponsors

U.O. Terapia Intensiva
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients with acute abdomen undergoing abdominal surgery on an urgent and present on arrival in type at least one sign of ipoperfusione. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Patients with chronic renal failure already undergoing dialysis treatment. SCA 5 units of EC) Patients with values of ≥ 5 PVC mmHg Patients on the list for OLT Patients with age less than 18 years

Design outcomes

Primary

MeasureTime frame
Main Objective: Objective of the study is to evaluate differences between two groups treated with different fluidic strategy in terms of mortality at thirty days;Secondary Objective: Secondary objectives are to evalaute differences between two groups treated with different strategy in terms of fluidic surgical complications, onset of organ failure, duration of mechanical ventilation and length of stay in intensive care.;Primary end point(s): 1.Mortality to 30 days

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026